The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Future Directions in Reactive Oxygen Species Research: Translational Opportunities and Challenges
Abstract
Reactive oxygen species (ROS) are crucial for immune defense and cellular signaling, but their overproduction can damage cells and contribute to diseases. Understanding this duality is essential for developing ROS-based therapies. Future treatments might target specific ROS types or their production mechanisms, offering promise for conditions like neurodegeneration, cardiovascular diseases, and certain cancers. Controlled ROS generation could enable targeted cancer cell killing or specific signaling pathway activation. ROS-based biomarkers could aid in early disease diagnosis and treatment monitoring. However, challenges include the complexity of ROS biology, lack of sensitive detection tools, and difficulties in translating research to clinical settings. Advanced techniques for precise ROS measurement and visualization are needed, along with ethical considerations to ensure safety and efficacy. Collaborative efforts are vital to unlock the potential of ROS research for novel therapeutic approaches.
Related Content
|
Dawn Prentice.
© 2026.
10 pages.
|
|
Yumi Tamura, Yuka Murata.
© 2026.
12 pages.
|
|
Carole A. Orchard.
© 2026.
22 pages.
|
|
Katsumi Fujitani.
© 2026.
10 pages.
|
|
Jenn Salfi.
© 2026.
12 pages.
|
|
Ralph A. Gigliotti, Sara E. Spear, Christine Goldthwaite.
© 2026.
24 pages.
|
|
Risa Suzuki.
© 2026.
28 pages.
|
|
|